SCHEMBL27468375

SCHEMBL27468375

C[C@@H](NC(=O)c1ccc(N2CCCCC2)nc1)C(=O)N1CCC2(CC1)CC2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 1/20 0.43
ALOX15 P16050 1/20 0.43
HPGDS O60760 2/20 0.42
MCHR1 Q99705 1/20 0.42
UBE2T Q9NPD8 1/20 0.41
HRH3 Q9Y5N1 2/20 0.41
ITGB3 P05106 2/20 0.40
ITGA2B P08514 2/20 0.40
CYP3A4 P08684 2/20 0.40
KCNH2 Q12809 1/20 0.40
HDAC1 Q13547 1/20 0.40
KCNQ3 O43525 1/20 0.40
KCNQ2 O43526 1/20 0.40
TRPV1 Q8NER1 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27467282 1.00 ALDH1A1 (0.44) ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E
SCHEMBL27468377 1.00 ALDH1A1 (0.44) ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E
SCHEMBL27468184 0.90 ALDH1A1 (0.52) ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E
SCHEMBL27467166 0.90 ALDH1A1 (0.52) ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E
SCHEMBL27468183 0.90 ALDH1A1 (0.52) ALDH1A1HPGDSMN1; SMN2HSD17B10KDM4E
SCHEMBL27467918 0.85 ITGB3 (0.40) ALDH1A1HPGDSMN1; SMN2HSD17B10ITGB3
SCHEMBL27467921 0.85 ITGB3 (0.40) ALDH1A1HPGDSMN1; SMN2HSD17B10ITGB3
SCHEMBL27466997 0.85 ITGB3 (0.40) ALDH1A1HPGDSMN1; SMN2HSD17B10ITGB3
SCHEMBL27467468 0.84 ITGB3 (0.38) ALDH1A1KDM4EPOLBITGB3ITGA2B
SCHEMBL27468608 0.84 ITGB3 (0.38) ALDH1A1KDM4EPOLBITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024108147-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2024-05-23 WO disclosed